{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,5]],"date-time":"2026-10-05T19:51:16Z","timestamp":1791229876602,"version":"4.1.0"},"reference-count":28,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2023,6,1]],"date-time":"2023-06-01T00:00:00Z","timestamp":1685577600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,6,1]],"date-time":"2023-06-01T00:00:00Z","timestamp":1685577600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,2,24]],"date-time":"2023-02-24T00:00:00Z","timestamp":1677196800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["fertstertreports.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["F&S Reports"],"published-print":{"date-parts":[[2023,6]]},"DOI":"10.1016\/j.xfre.2023.02.011","type":"journal-article","created":{"date-parts":[[2023,2,28]],"date-time":"2023-02-28T02:23:09Z","timestamp":1677550989000},"page":"15-19","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"special_numbering":"S","title":["GnRHa trigger\u2014the story of the ugly duckling"],"prefix":"10.1016","volume":"4","author":[{"given":"Peter","family":"Humaidan","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9304-5299","authenticated-orcid":false,"given":"Thor","family":"Haahr","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.xfre.2023.02.011_bib1","doi-asserted-by":"crossref","first-page":"918","DOI":"10.1210\/jcem-71-4-918","article-title":"Use of gonadotropin-releasing hormone agonist to trigger follicular maturation for in\u00a0vitro fertilization","volume":"71","author":"Gonen","year":"1990","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.xfre.2023.02.011_bib2","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1016\/S0015-0282(16)54474-4","article-title":"Induction of preovulatory luteinizing hormone surge and prevention of ovarian hyperstimulation syndrome by gonadotropin-releasing hormone agonist","volume":"56","author":"Itskovitz","year":"1991","journal-title":"Fertil Steril"},{"key":"10.1016\/j.xfre.2023.02.011_bib3","doi-asserted-by":"crossref","first-page":"644","DOI":"10.1093\/humrep\/16.4.644","article-title":"Comparable clinical outcome using the GnRH antagonist ganirelix or a long protocol of the GnRH agonist triptorelin for the prevention of premature LH surges in women undergoing ovarian stimulation","volume":"16","year":"2001","journal-title":"Hum Reprod"},{"key":"10.1016\/j.xfre.2023.02.011_bib4","doi-asserted-by":"crossref","first-page":"294","DOI":"10.1093\/humrep\/13.2.294","article-title":"First established pregnancy after controlled ovarian hyperstimulation with recombinant follicle stimulating hormone and the gonadotrophin-releasing hormone antagonist ganirelix (Org 37462)","volume":"13","author":"Itskovitz-Eldor","year":"1998","journal-title":"Hum Reprod"},{"key":"10.1016\/j.xfre.2023.02.011_bib5","doi-asserted-by":"crossref","first-page":"917","DOI":"10.1016\/S0015-0282(97)81407-0","article-title":"Comparison of different doses of gonadotropin-releasing hormone antagonist Cetrorelix during controlled ovarian hyperstimulation","volume":"67","author":"Albano","year":"1997","journal-title":"Fertil Steril"},{"key":"10.1016\/j.xfre.2023.02.011_bib6","doi-asserted-by":"crossref","first-page":"356","DOI":"10.1016\/j.fertnstert.2015.10.014","article-title":"Gonadotropin-releasing hormone agonist trigger in oocyte donors co-treated with a gonadotropin-releasing hormone antagonist: a dose-finding study","volume":"105","author":"Vuong","year":"2016","journal-title":"Fertil Steril"},{"key":"10.1016\/j.xfre.2023.02.011_bib7","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1093\/humrep\/dez235","article-title":"The early luteal hormonal profile in IVF patients triggered with hCG","volume":"35","author":"Vuong","year":"2020","journal-title":"Hum Reprod"},{"key":"10.1016\/j.xfre.2023.02.011_bib8","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1016\/j.fertnstert.2010.03.028","article-title":"Preventing ovarian hyperstimulation syndrome: guidance for the clinician","volume":"94","author":"Humaidan","year":"2010","journal-title":"Fertil Steril"},{"key":"10.1016\/j.xfre.2023.02.011_bib9","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1080\/14647270701194143","article-title":"Odds of ovarian hyperstimulation syndrome (OHSS) - time for reassessment","volume":"10","author":"Mocanu","year":"2007","journal-title":"Hum Fertil (Camb)"},{"key":"10.1016\/j.xfre.2023.02.011_bib11","doi-asserted-by":"crossref","first-page":"1997","DOI":"10.1093\/humrep\/dew149","article-title":"Ovarian hyperstimulation syndrome: review and new classification criteria for reporting in clinical trials","volume":"31","author":"Humaidan","year":"2016","journal-title":"Hum Reprod"},{"key":"10.1016\/j.xfre.2023.02.011_bib12","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1080\/03009734.2020.1736696","article-title":"Gonadotropin-releasing hormone agonist for ovulation trigger - OHSS prevention and use of modified luteal phase support for fresh embryo transfer","volume":"125","author":"Castillo","year":"2020","journal-title":"Ups J Med Sci"},{"key":"10.1016\/j.xfre.2023.02.011_bib13","doi-asserted-by":"crossref","first-page":"188","DOI":"10.1097\/GCO.0000000000000682","article-title":"IVF and the exogenous progesterone-free luteal phase","volume":"33","author":"Kol","year":"2021","journal-title":"Curr Opin Obstet Gynecol"},{"key":"10.1016\/j.xfre.2023.02.011_bib14","doi-asserted-by":"crossref","first-page":"1213","DOI":"10.1093\/humrep\/deh765","article-title":"GnRH agonist (buserelin) or hCG for ovulation induction in GnRH antagonist IVF\/ICSI cycles: a prospective randomized study","volume":"20","author":"Humaidan","year":"2005","journal-title":"Hum Reprod"},{"key":"10.1016\/j.xfre.2023.02.011_bib15","doi-asserted-by":"crossref","first-page":"2887","DOI":"10.1093\/humrep\/dei150","article-title":"A lower ongoing pregnancy rate can be expected when GnRH agonist is used for triggering final oocyte maturation instead of HCG in patients undergoing IVF with GnRH antagonists","volume":"20","author":"Kolibianakis","year":"2005","journal-title":"Hum Reprod"},{"key":"10.1016\/j.xfre.2023.02.011_bib16","doi-asserted-by":"crossref","first-page":"616","DOI":"10.1016\/j.fertnstert.2006.12.006","article-title":"Triggering of final oocyte maturation with gonadotropin-releasing hormone agonist or human chorionic gonadotropin. Live birth after frozen-thawed embryo replacement cycles","volume":"88","author":"Griesinger","year":"2007","journal-title":"Fertil Steril"},{"key":"10.1016\/j.xfre.2023.02.011_bib17","doi-asserted-by":"crossref","first-page":"2126","DOI":"10.1093\/humrep\/del119","article-title":"Hormonal characteristics of follicular fluid from women receiving either GnRH agonist or CG for ovulation induction","volume":"21","author":"Andersen","year":"2006","journal-title":"Hum Reprod"},{"key":"10.1016\/j.xfre.2023.02.011_bib18","doi-asserted-by":"crossref","first-page":"2034","DOI":"10.1016\/j.fertnstert.2011.02.013","article-title":"Levels of the epidermal growth factor-like peptide amphiregulin in follicular fluid reflect the mode of triggering ovulation: a comparison between gonadotrophin-releasing hormone agonist and urinary human chorionic gonadotrophin","volume":"95","author":"Humaidan","year":"2011","journal-title":"Fertil Steril"},{"key":"10.1016\/j.xfre.2023.02.011_bib19","doi-asserted-by":"crossref","first-page":"2511","DOI":"10.1093\/humrep\/det249","article-title":"GnRHa trigger and individualized luteal phase hCG support according to ovarian response to stimulation: two prospective randomized controlled multi-centre studies in IVF patients","volume":"28","author":"Humaidan","year":"2013","journal-title":"Hum Reprod"},{"key":"10.1016\/j.xfre.2023.02.011_bib20","doi-asserted-by":"crossref","first-page":"847","DOI":"10.1016\/j.fertnstert.2008.12.042","article-title":"1,500 IU human chorionic gonadotropin administered at oocyte retrieval rescues the luteal phase when gonadotropin-releasing hormone agonist is used for ovulation induction: a prospective, randomized, controlled study","volume":"93","author":"Humaidan","year":"2010","journal-title":"Fertil Steril"},{"key":"10.1016\/j.xfre.2023.02.011_bib21","doi-asserted-by":"crossref","first-page":"1108","DOI":"10.1016\/j.rbmo.2021.03.011","article-title":"The exogenous progesterone-free luteal phase: two pilot randomized controlled trials in IVF patients","volume":"42","author":"Humaidan","year":"2021","journal-title":"Reprod Biomed Online"},{"key":"10.1016\/j.xfre.2023.02.011_bib22","first-page":"CD008046","article-title":"Gonadotropin-releasing hormone agonist versus HCG for oocyte triggering in antagonist-assisted reproductive technology","author":"Youssef","year":"2014","journal-title":"Cochrane Database of Syst Rev"},{"key":"10.1016\/j.xfre.2023.02.011_bib23","first-page":"CD008046","article-title":"Gonadotropin-releasing hormone agonist versus HCG for oocyte triggering in antagonist assisted reproductive technology cycles","author":"Youssef","year":"2010","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.xfre.2023.02.011_bib24","first-page":"CD003719","article-title":"Recombinant versus urinary human chorionic gonadotrophin for final oocyte maturation triggering in IVF and ICSI cycles","author":"Youssef","year":"2011","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.xfre.2023.02.011_bib25","doi-asserted-by":"crossref","first-page":"563","DOI":"10.1016\/j.rbmo.2015.02.009","article-title":"The updated Cochrane review 2014 on GnRH agonist trigger: repeating the same errors","volume":"30","author":"Kol","year":"2015","journal-title":"Reprod Biomed Online"},{"key":"10.1016\/j.xfre.2023.02.011_bib26","doi-asserted-by":"crossref","first-page":"1321","DOI":"10.1038\/nm0912-1321","article-title":"(Meta)analyze this: Systematic reviews might lose credibility","volume":"18","author":"Humaidan","year":"2012","journal-title":"Nat Med"},{"key":"10.1016\/j.xfre.2023.02.011_bib27","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1016\/j.fertnstert.2016.10.011","article-title":"Gonadotropin-releasing hormone analogue as sole luteal support in antagonist-based assisted reproductive technology cycles","volume":"107","author":"Bar Hava","year":"2017","journal-title":"Fertil Steril"},{"key":"10.1016\/j.xfre.2023.02.011_bib28","doi-asserted-by":"crossref","first-page":"330","DOI":"10.1016\/j.fertnstert.2016.04.004","article-title":"Intranasal gonadotropin-releasing hormone agonist (GnRHa) for luteal-phase support following GnRHa triggering, a novel approach to avoid ovarian hyperstimulation syndrome in high responders","volume":"106","author":"Bar-Hava","year":"2016","journal-title":"Fertil Steril"},{"key":"10.1016\/j.xfre.2023.02.011_bib29","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0149615","article-title":"Prediction of ovarian hyperstimulation syndrome in patients treated with corifollitropin alfa or rFSH in a GnRH antagonist protocol","volume":"11","author":"Griesinger","year":"2016","journal-title":"PLoS ONE"}],"container-title":["F&S Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2666334123000302?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2666334123000302?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,2,2]],"date-time":"2025-02-02T17:02:47Z","timestamp":1738515767000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2666334123000302"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,6]]},"references-count":28,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2023,6]]}},"alternative-id":["S2666334123000302"],"URL":"https:\/\/doi.org\/10.1016\/j.xfre.2023.02.011","relation":{},"ISSN":["2666-3341"],"issn-type":[{"value":"2666-3341","type":"print"}],"subject":[],"published":{"date-parts":[[2023,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"GnRHa trigger\u2014the story of the ugly duckling","name":"articletitle","label":"Article Title"},{"value":"F&S Reports","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.xfre.2023.02.011","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 The Authors. Published by Elsevier Inc. on behalf of American Society for Reproductive Medicine.","name":"copyright","label":"Copyright"}]}}